Skip to main content
. 2012 Dec;16(4):191–200. doi: 10.1177/1084713812465493

Table 1.

Cochlear Implant (CI) User Demographics

Participant Sex Age Etiology Profound deafness (years) CI experience (years) Device Processor
CI1 F 58 Idiopathic 18 2.8 Med-El SonataTi100 Opus II
CI2 M 61 Meniere’s 4 3.7 Med-El SonataTi100 Opus II
CI3a F 47 Autoimmune 9 3 Med-El SonataTi100 Opus II
CI4a M 35 Idiopathic 4 2.3 ABC HiRes 90K Harmony
CI5 M 58 Meniere’s 11 11 ABC Clarion Harmony
CI6a M 57 Meniere’s 3 2.2 Med-El SonataTi100 Opus II
CI7a F 56 Idiopathic 7 4.9 ABC HiRes 120 Harmony
CI8a M 51 Idiopathic 15 14.3 ABC HiRes 120 Harmony
CI9 F 47 Autoimmune 1 1 Med-El SonataTi100 Opus II
CI10a F 58 Autoimmune 15 2 ABC Clarion CII Harmony
CI11 F 26 Meniere’s 8 3.7 CC Nucleus 22 Freedom
CI12a F 41 Idiopathic 4 1.5 ABC HiRes 90K Harmony

Note: ABC = Advanced Bionics Corporation; CC = Cochlear Corporation; F = female; M = male.

a

These participants were bilateral CI recipients; demographics correspond to implant side with that was tested in this study.